FFAR2 and neoplasm: Additionally, co-injection of Ffar2−/− MDSCs markedly delayed tumor growth than Ffar2+/+ MDSCs both in LLC (Fig. 4C) and B16F10 (Additional file 1: Fig. S6B and C) tumor models.